Galym ImanbayevinLightspeed Venture PartnersTaking the time to do it right: Automation in medical coding comes of age, thanks to FathomLightspeed backs Fathom’s automation platform to reduce billions of dollars of waste in the health systemNov 9, 2022Nov 9, 2022
Galym ImanbayevinLightspeed Venture PartnersState of Healthcare Investing — A Lightspeed PerspectiveDespite the recent market downturn, we at Lightspeed continue to be upbeat about investing in healthcare. While the past few months showed…Aug 31, 20222Aug 31, 20222
Galym ImanbayevinLightspeed Venture PartnersAncora Biotech: TeneoTwo Acquisition & What’s NextBy Galym Imanbayev and Jonathan MacQuittyJul 5, 2022Jul 5, 2022
Galym ImanbayevinLightspeed Venture PartnersAncora: Advancing antibodies from the lab to patient treatmentsLightspeed continues its relationship with the Teneobio team to get antibody trio into patient handsJun 9, 2022Jun 9, 2022
Galym ImanbayevinLightspeed Venture PartnersFunctional genomics — Skating to where the puck is goingBy Jonathan MacQuitty & Galym ImanbayevDec 7, 2021Dec 7, 2021
Galym ImanbayevinLightspeed Venture PartnersDigital therapeutics — identifying the hurdles and establishing the evidence for transformational…By Jonathan MacQuitty & Galym ImanbayevNov 19, 2021Nov 19, 2021